VISTA PHARMA Fact Sheet, VISTA PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA Fact Sheet    (VAPH)


FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit


Here is the latest financial fact sheet of VISTA PHARMA. For more details, see the VISTA PHARMA quarterly results and VISTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

VISTA PHARMA Price History

Price Rs 10.4
Mkt Cap Rs m 382
Vol '000 30.1
P/E X -12.4
P/CF X -33.0
EPS (TTM) Rs -0.8
% ch % 2.4
No. of shares m 36.79
% ch week % 7.2
% ch 1-mth % 2.6
% ch 12-mth % 29.9
52 week H/L Rs 17.6/7.4
(As on Nov 29, 2021 02:15:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

VISTA PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
VISTA PHARMA EQUITY SHARE DATA
High Rs3756442116 
Low Rs13261855 
Sales per share (Unadj.) Rs9.19.910.27.50.3 
Earnings per share (Unadj.) Rs0.50.80.3-1.2-0.5 
Diluted earnings per shareRs0.30.60.3-1.0-0.5 
Cash flow per share (Unadj.) Rs0.91.20.8-0.8-0.3 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs6.39.011.09.88.9 
Adj. book value per shareRs4.57.19.18.18.9 
Shares outstanding (eoy) m26.5729.1530.3730.3736.79 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x2.74.13.11.730.3 
Avg P/E ratio x52.854.6101.6-10.4-20.4 
P/CF ratio (eoy) x29.133.941.4-16.4-33.2 
Price / Book Value ratio x4.04.52.91.31.2 
Dividend payout %00000 
Avg Mkt Cap Rs m6591,193954383384 
No. of employees `000NANANANANA 
Total wages/salary Rs m79121312 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
VISTA PHARMA INCOME DATA
Net Sales Rs m24228931122813 
Other income Rs m1429373 
Total revenues Rs m24229334026516 
Gross profit Rs m315312-48-17 
Depreciation Rs m101314137 
Interest Rs m916171515 
Profit before tax Rs m122811-39-37 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m062-3-18 
Profit after tax Rs m12229-37-19 
Gross profit margin %12.618.54.0-21.1-136.6 
Effective tax rate %-2.022.718.16.648.9 
Net profit margin %5.27.63.0-16.2-148.9 
VISTA PHARMA BALANCE SHEET DATA
Current assets Rs m255278234212152 
Current liabilities Rs m18915210915992 
Net working cap to sales %27.243.740.223.1473.2 
Current ratio x1.31.82.11.31.6 
Inventory Days Days11122,409 
Debtors Days Days136137981,6496,254 
Net fixed assets Rs m155249292296374 
Share capital Rs m5358616174 
"Free" reserves Rs m113205272236255 
Net worth Rs m166263333296328 
Long term debt Rs m6059605587 
Total assets Rs m410527526507526 
Interest coverage x2.42.81.7-1.6-1.4 
Debt to equity ratio x0.40.20.20.20.3 
Sales to assets ratio x0.60.50.60.40 
Return on assets %5.27.15.0-4.2-0.6 
Return on equity %7.58.32.8-12.4-5.7 
Return on capital %9.313.77.2-6.8-5.1 
Exports to sales %60.474.721.418.50 
Imports to sales %06.4000 
Exports (fob) Rs m14621667420 
Imports (cif) Rs m019000 
Fx inflow Rs m14621868441 
Fx outflow Rs m019100 
Net fx Rs m14620067441 
VISTA PHARMA CASH FLOW
From Operations Rs m 26 -46 33 8 -67 
From Investments Rs m -36 -106 -56 -17 -3 
From Financial Activity Rs m 64 112 14 3 70 
Net Cashflow Rs m 53 -40 -9 -6 -1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 36.9%
Institution 0.2%
Non-Institution 62.9%
Total 100.0%
Free Float 63.1%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Plot Nos. 10 To 14 And 16 To 20 T S I I C Industrial Estate, Chityal Gopalaipalli Village, Narketpally Mandal, Nalgonda Dist - 508254
E-MAIL admin.hyd@vistapharmaceuticals.com WEB www.vistapharmaceuticals.com
TEL 08682 272552 / 09291015956 FAX 08682-272551
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Aarthi Consultants Pvt Ltd, 1-2-285, Domalaguda
YEAR OF INC: 1991 BSE CODE: 524711 FV (Rs): 2 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   ANUH PHARMA  ZENLABS ETHICA  SANJIVANI PA  BIOFIL CHEMICALS  WINDLAS BIOTECH  

Compare VISTA PHARMA With:   ANUH PHARMA  ZENLABS ETHICA  SANJIVANI PA  BIOFIL CHEMICALS  WINDLAS BIOTECH  




Today's Market

Sensex Recoups Early Losses as Energy, Metal Stocks Rally; Reliance & Tata Steel Top Gainers(10:30 am)

Asian share markets are trading lower today as the spread of the Omicron variant in developed nations threatened to derail economic recoveries and the tightening plans of some central banks.

Views on news

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK VISTA PHARMA

  • Track your investment in VISTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VISTA PHARMA

VISTA PHARMA 8-QTR ANALYSIS

COMPARE VISTA PHARMA WITH

MARKET STATS